Matches in Wikidata for { <http://www.wikidata.org/entity/Q91896130> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q91896130 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91896130 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91896130 description "scientific article published on 14 April 2020" @default.
- Q91896130 description "wetenschappelijk artikel" @default.
- Q91896130 description "наукова стаття, опублікована 14 квітня 2020" @default.
- Q91896130 name "Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany" @default.
- Q91896130 name "Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany" @default.
- Q91896130 type Item @default.
- Q91896130 label "Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany" @default.
- Q91896130 label "Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany" @default.
- Q91896130 prefLabel "Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany" @default.
- Q91896130 prefLabel "Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany" @default.
- Q91896130 P1433 Q91896130-05F41B1E-79DC-4DC8-BF52-5E0636EDCE47 @default.
- Q91896130 P1476 Q91896130-BAA14030-409B-44CD-B4FE-5DA5C19A3091 @default.
- Q91896130 P2093 Q91896130-6C3CBCAC-0142-462D-8517-E96899FE76E4 @default.
- Q91896130 P2093 Q91896130-6C9FC6F0-C0AA-43F3-959B-D2392C62163E @default.
- Q91896130 P2093 Q91896130-A5E67462-6D98-4F0B-863A-FC96B0056590 @default.
- Q91896130 P2093 Q91896130-B9191C39-FF3A-4897-8914-5C9A772F4D7D @default.
- Q91896130 P2093 Q91896130-CD75EE7C-C5FC-48BC-95FA-03BA5482DBD4 @default.
- Q91896130 P31 Q91896130-88F3316A-465E-47D4-8CB4-74C2DA6A70BA @default.
- Q91896130 P356 Q91896130-7A14DBE2-6D7A-4AB1-B3AB-2F90E12ACD01 @default.
- Q91896130 P577 Q91896130-7740D2F5-35A0-4585-9A41-8336179C9C7F @default.
- Q91896130 P698 Q91896130-F607B7EC-BEB8-4D2B-A249-0C80152C50C8 @default.
- Q91896130 P921 Q91896130-485000DA-ABF1-4199-BE7A-9699C170D7A1 @default.
- Q91896130 P921 Q91896130-781A1FE6-2597-4484-AAEF-E52ABCEA32C2 @default.
- Q91896130 P356 FON-2020-0180 @default.
- Q91896130 P698 32286864 @default.
- Q91896130 P1433 Q2781597 @default.
- Q91896130 P1476 "Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany" @default.
- Q91896130 P2093 "Andra Kuske" @default.
- Q91896130 P2093 "Burkhard Otremba" @default.
- Q91896130 P2093 "Florian O Losch" @default.
- Q91896130 P2093 "Jens Borchardt" @default.
- Q91896130 P2093 "Maike Hollnagel-Schmitz" @default.
- Q91896130 P31 Q13442814 @default.
- Q91896130 P356 "10.2217/FON-2020-0180" @default.
- Q91896130 P577 "2020-04-14T00:00:00Z" @default.
- Q91896130 P698 "32286864" @default.
- Q91896130 P921 Q1138590 @default.
- Q91896130 P921 Q412323 @default.